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Introduction
Optimal treatment for ST-elevation myocardial infarction (STEMI) is based on a reperfusion strategy employing either primary percutaneous coronary intervention (PPCI) or thrombolytic therapy (TT). A sizable proportion of STEMI patients are not reperfused, time delays are frequently unacceptable 1 and very few patients receive all the guideline-recommended therapies in a timely manner. Decision-making in the pre-hospital setting is pivotal for optimal STEMI care, and delays in therapy cannot later be compensated.
Thus, the empowerment of paramedical staff is key to successful pre-hospital STEMI management. This requires the implementation of systems of care (STEMI networks), in which the Emergency Medical Service (EMS), non-PCI-capable hospitals, and hospitals with PCI facilities cooperate closely in order to reduce the total ischaemic time, increase the number of patients receiving reperfusion therapy, and to reduce heart failure and mortality 2 .
Delays
The total ischaemic time ( Figure 1 ) is often unacceptably long with only 11-15% patients treated within the recommended time intervals. 3 Patient delay. An early first call to the EMS is desirable as rapid diagnosis and treatment at the scene has been shown to save lives and prevent complications. The patient's decision time (PDT) has historically remained constant at between 1-3 hours. Patients with longer PDTs tend to be older, female and diabetic, with atypical symptoms. There is significant variation in the use of EMS in STEMI (28-82% patients) and in the PDTs (81-174 mins) throughout Europe. While several public initiatives have been successful in shortening PDTs, such campaigns have only a temporary impact.
An integral part of the EMS is triage by the emergency medical dispatcher. First medical contact is defined as the time at which STEMI diagnosis is made using ECG, irrespective of the setting.
Pre-hospital organisation. Not all patients referred for PPCI receive optimal percutaneous reperfusion (i.e.
PCI performed in a timely manner by an experienced team), and even in urban locations a minority still require pre-hospital thrombolysis (PH-T) 4 . Geographical considerations and distribution of PPCI centres are two factors that contribute to the variability in European rates (5-92%). 5 The best evidence for reperfusion strategies is based on in-hospital STEMI studies, and more high-quality research on the pre-hospital environment is needed. The key to diagnosis is the pre-hospital electrocardiogram (PH-ECG) 6 , interpreted on site and/or transmitted for interpretation
Pre-hospital ECG
The use of the PH-ECG is widespread in some countries and has been shown to reduce the time to reperfusion and mortality in patients with STEMI. Trained paramedics can identify STEMI with a good sensitivity and specificity, with multiple studies demonstrating that PH-ECGs decrease door-to-needle (D2N)
and door-to-balloon (D2B) times. 
Registries and STEMI networks: organization and outcome in practice
STEMI mortality reported in registries is higher than in randomized clinical trials (RCTs). As the results of RCTs may only be applicable to 50% of patients in clinical practice, registry data may provide additional information, including the challenges in implementing RCT-derived recommendations. As shown from registry data, an increase in the PPCI-related delay (D2B minus D2N time) is associated with higher mortality rates. The time point at which PPCI loses its survival advantage over fibrinolysis varies considerably between subgroups, from <1 hour to 3 hours 9 . Registry data also show that field transfer is faster than inter-hospital transfer, resulting in more patients achieving a D2B time < 90mins. The main findings 10-13 of selected European registries on pre-hospital STEMI care are shown in Table 1 .
Pre-hospital adjuvant therapies
Several recommendations have been made to attempt to standardise care and reduce major adverse cardiac 4 events (MACE) and mortality in pre-hospital STEMI management (Table 2) . Some drugs effective for inhospital STEMI treatment are not indicated (GP IIb/IIIa inhibitors) or are lacking data in the pre-hospital setting (prasugrel, bivalirudin).
Pre-hospital management of STEMI complications
Timely and appropriate pre-hospital management can stabilise the patient, enabling safe transportation to the most appropriate hospital for more definite treatment.
Cardiac arrest. The highest proportion of deaths due to MI occur early during the pre-hospital phase, before any medical support is at hand. The commonest cause is ventricular fibrillation, induced by ischaemia and reperfusion. In patients with no return of spontaneous circulation (ROSC), TT does not improve survival 14 .
PPCI is an alternative for reperfusion in survivors of out-of-hospital cardiac arrest, and may be an independent predictor of survival. 15 Therapeutic hypothermia should be part of the standardised treatment strategy for comatose survivors of cardiac arrest.
Cardiac arrhythmias. Arrhythmias are associated with increased mortality in acute coronary syndromes (ACS). Basic and advanced life-support algorithms and defibrillation/cardioversion should be applied where indicated. Beta-blockers and amiodarone may be considered in case of ventricular tachyarrhythmias; alternative drugs are class 1A/1B antiarrhythmics.
Acute bradycardia due to STEMI. Complete heart block during STEMI is associated with a high mortality rate. Severe bradycardia and high-grade atrio-ventricular block may be reversed by i.v. atropine sulfate in inferior or posterior acute myocardial infarction (AMI), while in anterior AMI emergency pacing may be required.
Pulmonary oedema. Heart failure during STEMI is associated with poor short-and long-term prognosis, and PPCI is preferred in STEMI complicated by pulmonary oedema. Minor degrees of pulmonary oedema often respond to nitrates and diuretics, and in the absence of hypotension, i.v. nitroglycerine should be administered except in the presence of right ventricular infarction. Oxygen should be administered to patients with breathlessness and/or clinical signs of heart failure and/or cardiogenic shock (CS), and continuous positive airway pressure or endotracheal intubation with ventilatory support may be required. 16 
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Morphine should be used only when clinically indicated.
Cardiogenic shock. CS complicates AMI in 2.8-11% of cases, with a median time from AMI onset of 6.2 hours, and a mortality rate > 50%. PPCI is the preferred option in patients with CS and high-risk features, 17 with TT where PPCI is likely to be delayed. Early diagnosis and treatment of established and developing CS is paramount. Here patients should be transported to PCI-and intra-aortic balloon pump-capable hospitals.
Pre-hospital treatment of CS includes volume administration (in the absence of pulmonary oedema), oxygen (to achieve O 2 saturation > 95%), and inotropic support (dobutamine and dopamine) if the systolic blood pressure is <90 mmHg. In such cases, a low threshold for intubation and mechanical ventilation exists.
Right ventricular infarction.This should be suspected where the clinical picture is of hypotension, clear lung fields and a raised jugular venous pressure in a patient with an inferior STEMI. ST-segment elevation in V 4 R is also suggestive. Right ventricular preload should be maintained and vasodilators avoided. Although limited fluid expansion is effective in many cases, additional inotropic support may be required. PPCI is the preferred therapeutic option, with TT where PPCI is likely to be delayed.
Education
The educational challenges for improved pre-hospital care are considerable, ranging from EMS personnel to hospital-based cardiologists, nurses and other paramedical staff, funding bodies, policy makers and planners of health care.
EMS systems vary in their approach to receiving and prioritising emergency calls, ranging from a physician to computerised priority dispatch algorithms. EMS models can be dichotomised as the Franco-German model (physicians in the control room and in ambulances), or the Anglo-American mode (paramedics/emergency medical technician-staffed ambulances, working to agreed protocols, supported by physician direction and/or telemedicine). The duration of training and degree of autonomy varies widely between programmes.
The knowledge, skills and behaviours outlined in the ACS section of the ESC Core Curriculum for the general cardiologist could be expected to apply, in various degrees, to all professionals engaged in prehospital STEMI care. Education of EMS staff in clinical research is of value, to facilitate safe and ethical recruitment to approved, well-designed studies.
Training
The need for a medical specialty. Emergency medicine (EM) is the medical specialty with the principal mission of evaluating, managing, treating and preventing unexpected illness and injury. It is a practice in which time is critical. The second EuSEM Core Curriculum for emergency medicine stated a minimum of 5 years in a recognised training program for EM specialists. 18 The need for a cardiological sub-specialty. Patients admitted to the Intensive Cardiac Care Units (ICCUs)
are increasingly older, have more severe cardiac conditions and associated comorbidities, with more than 50% having important co-morbidities. To deliver optimal treatment to this patient population requires cardiologists to have full knowledge of the range of techniques and procedures required in intensive acute cardiac care (IACC). 19 Cardiologists working in ICCUs must therefore adapt their knowledge and abilities to these new demands. The process of certification in IACC should standardise training in the specialty and facilitate delivery of state-of-the-art treatment to patients admitted to ICCUs in Europe.
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Summary and conclusions
The pre-hospital phase is the most critical in STEMI treatment. Minimising patient-related delay is the first key step in STEMI treatment: public/patient education campaigns, community organisation, and the presence of an unique European-wide emergency telephone number may be advisable. The availability of automated external defibrillators (AEDs) in public places may be of value. The ambulance service has a pivotal role in STEMI management and cardiac arrest. All emergency ambulances should be equipped with defibrillators, 12-lead electrocardiographs and staffed with at least one person proficient in advanced cardiac life support.
ECG transmission/ teleconsultation may be useful.
Implementation of systems of care has a pivotal role in modern STEMI treatment, based on networks among medical and cardiology institutions of different technological levels, connected by an effective EMS. There are two main models of transfer; the hub-and-spoke transfer system and the STEMI receiving centre (SRC).
In the first model, patients presenting to a non-PCI capable hospital are either treated with TT or immediately transferred for PPCI. In the second model, non-SRC are bypassed by transport systems, delivering patients directly to an experienced PPCI centre. An additional option has been proposed with experienced interventionalists undertaking PPCI in peripheral catheter laboratories. PPCI is the preferred treatment option for STEMI when performed within guideline times, with the maximal acceptable PPCIrelated delay <120 min (<90 min for young early presenters) 7 . Where PH-T is performed, this results in a reduction of 15-20% in early mortality, when compared with IH-T, and the combination of PH-T with early (but not immediate) coronary angiography and PCI further improves patients' outcome. Appropriately educated and motivated healthcare professionals are central to overcoming existing barriers to provide optimal patient care. Scientific societies have a critical role in promoting research and guideline implementation, whilst taking into account the the economic imbalances, and diversity of healthcare systems amongst the European countries. 5 Finally, adequate involvement of political and administrative bodies is mandatory.
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Legend Figure 1 Components of total delay to reperfusion in patients with STEMI. Redrawn after Fox & Huber. 
